Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment
Related Experiment Video
Updated: Oct 26, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Harekrishna Roy1, Asha Gummadi1, Bhabani Shankar Nayak2
1Department of Pharmaceutics, Nirmala College of Pharmacy, Mangalagiri, Guntur, Affiliated to Acharya Nagarjuna University, Andhra Pradesh, 522503, India.
Background:
The novel strain SARS-CoV-2 of coronavirus diseases (COVID-19) became pandemic at the end of 2019 with an unprecedented global crisis by infecting around 11 million people in more than 200 countries. The condition has now been provoked by the demand, supply, and liquidity shocks that COVID-19 has attacked the lives of a vast population.
Objectives:
Researchers are therefore trying to encode and understand the viral genome sequence along with various potential targets to explore the transmission mechanism and the mode of treatment for COVID-19. The important structural proteins such as nucleocapsid protein (N), membrane protein (M), an envelope protein (E), and spike protein (S) related to COVID-19 are discussed in this manuscript.
Methods:
The topology of these various targets has been explored utilizing structure-based design and crystallographic studies.
Results:
The literature reported that the N-protein processes the viral genome to the host cell during replication. The "N-terminal domain" and "C-terminal domain" contribute towards localization in the endoplasmic region and dimerization respectively. The M protein determines the shape of coronavirus and also assists the S protein to integrate with the Golgi-endoplasmic region complex leading to the stabilization of the virion. The smallest hydrophobic viroporin termed "E" takes part in morphogenesis and pathogenesis during intracellular infection. The viral spike (S) protein attaches the cellular receptors and initiates virus-cell membrane fusions. The main protease in the proteolytic process during viral gene expression and replication has also been discussed.
Conclusion:
Currently, there is no permanent cure and treatment of COVID-19 hence researchers are repurposing a suitable combination of drugs including antiviral, antimalarial, antiparasitic, and antibacterial, hypertensive receptor blockers, immunosuppressants, anti-arthritis drugs, including ayurvedic formulations. In brief, it is justified that, for complete recovery, there is a need for deep and elaborate studies on genomic sequences and invading mechanisms in the host cell.
Insights
This study explores key structural proteins of SARS-CoV-2, including nucleocapsid (N), membrane (M), envelope (E), and spike (S) proteins, to understand COVID-19 transmission and treatment. Further research into viral genomics and host cell invasion is crucial for recovery.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has created a global health crisis.
- Understanding the virus's structure and function is critical for developing effective treatments.
Purpose of the Study:
- To analyze the structural proteins of SARS-CoV-2: nucleocapsid (N), membrane (M), envelope (E), and spike (S).
- To explore potential therapeutic targets and understand viral transmission mechanisms.
Main Methods:
- Structure-based drug design.
- Crystallographic studies to determine protein topology.
Main Results:
- N-protein facilitates viral genome processing and localization.
- M protein influences virion shape and stabilization with the Golgi-endoplasmic reticulum.
- E protein is involved in viral morphogenesis and pathogenesis.
- S protein mediates viral entry by attaching to cellular receptors.
Conclusions:
- No definitive cure for COVID-19 exists; drug repurposing is underway.
- Comprehensive studies on viral genomics and host cell interactions are essential for developing treatments.
More Related Videos
Related Concept Videos
Drug Discovery: Overview
Microorganisms in Medicine and Therapeutics
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against...

